These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8415248)
1. [Trimetazidine therapy in atrio-cochlear disturbances of vascular origin]. Kozakiewicz K; Wróbel M; Petelenz T; Lepkowski A; Skrzypek-Wańha J; Chruściel TL Pol Tyg Lek; 1993 Apr 5-12; 48(14-15):327-9. PubMed ID: 8415248 [TBL] [Abstract][Full Text] [Related]
2. [The efficacy of trimetazidine in cochleovestibular disorders of ischemic origin. A crossover control versus placebo trial]. Coyas A Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():82-7. PubMed ID: 2241007 [TBL] [Abstract][Full Text] [Related]
3. [Dynamics of cochleovestibular disorders in patients with early manifestations of cerebral circulation insufficiency]. Kuklina EV Vestn Otorinolaringol; 1989; (4):13-6. PubMed ID: 2800118 [TBL] [Abstract][Full Text] [Related]
4. [Ischemic cochlear vestibular syndromes]. Putilina MV Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6):35-9. PubMed ID: 22983237 [No Abstract] [Full Text] [Related]
5. [Therapeutic policy in cochleovestibular disorders in the presence of cerebral circulatory insufficiency]. Kunel'skaia NL; Kamchatnov PR; Gulieva AE Vestn Otorinolaringol; 2008; (1):47-50. PubMed ID: 18454057 [No Abstract] [Full Text] [Related]
6. [Cavinton in the treatment of cochleovestibular disorders of vascular genesis]. Kunel'skaia NL; Gulieva AE; Ianiushkina ES; Chugunova MI Vestn Otorinolaringol; 2009; (5):52-4. PubMed ID: 20041504 [No Abstract] [Full Text] [Related]
7. [Betaserk efficiency in cochlear and vestibular disorders in the regional surdocenter]. Pekaskiĭ SI Vestn Otorinolaringol; 2001; (3):61. PubMed ID: 11510053 [TBL] [Abstract][Full Text] [Related]
8. [Use of monotreane in the treatment of patients with cochleovestibular disorders]. Pal'chun VT; Kadymova MI; Kriukov AI Vestn Otorinolaringol; 1989; (5):20-2. PubMed ID: 2588407 [TBL] [Abstract][Full Text] [Related]
9. [Angiogenic cochleo-vestibular diseases and dyslipoproteinemia: new insight]. Petukhova NA Vestn Otorinolaringol; 2002; (2):52-4. PubMed ID: 12056167 [No Abstract] [Full Text] [Related]
10. [The estimation of the efficacy of manual therapy included in the combined treatment of cochlear-vestibular disorders based on the results of computed stabilography]. Shempeleva AÉ; Lopatin AS; Morozova SV; Gridin LA Vestn Otorinolaringol; 2012; (2):45-8. PubMed ID: 22810637 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of effectiveness of treatment of cochleovestibular disorders with mildronate]. Luchikhin LA; Pankova TB; Kakymov MI Vestn Otorinolaringol; 1991; (2):36-40. PubMed ID: 2048251 [TBL] [Abstract][Full Text] [Related]
12. [The use of betaserk in patients with cochlear-vestibular disorders]. Kadymov MI; Poliakova TS; Vladimirova TN Vestn Otorinolaringol; 1998; (5):49-50. PubMed ID: 9793432 [TBL] [Abstract][Full Text] [Related]
13. [Vestibo in the treatment of cochleovestibular disorders]. Kunel'skaia NL; Levina IuV; Doronina OM; Krasiuk AA; Izotova GN Vestn Otorinolaringol; 2008; (6):52-4. PubMed ID: 19209416 [No Abstract] [Full Text] [Related]